928
R. AGGARWAL, C. RANI, AND G. SUMRAN
quinoxaline 1,4-di-N-oxide with antileishmanial and antimalarial activities. Bioorg. Med.
Chem. Lett. 2011, 21, 4498–4502; (b) Burguete, A.; Pontiki, E.; Hadjipavlou-Litina, D.;
Villar, R.; Vicente, E.; Solano, B.; Ancizu, S.; Perez-Silanes, S.; Aldanaa, I.; Mongea,
A. Synthesis and anti-inflammatory=antioxidant activities of some new ring substituted
3-phenyl-1-(1,4-di-N-oxide quinoxalin-2-yl)-2-propen-1-one derivatives and of their
4,5-dihydro-(1H)-pyrazole analogues. Bioorg. Med. Chem. Lett. 2007, 17, 6439–6443; (c)
Estevez, Y.; Quiliano, M.; Burguete, A.; Cabanillas, B.; Zimic, M.; Malaga, E.;
Verastegui, M.; Perez-Silanes, S.; Aldana, I.; Monge, A.; Castillo, D.; Deharo, E.
Trypanocidal properties, structure–activity relationship, and computational studies of
quinoxaline 1,4-di-N-oxide derivatives. Exp. Parasitol. 2011, 127, 745–751; (d) Ismail,
M. M. F.; Amin, K. M.; Noaman, E.; Soliman, D. H.; Ammar, Y. A. New quinoxaline
1,4-di-N-oxides: Anticancer and hypoxia-selective therapeutic agents. Eur. J. Med. Chem.
2010, 45, 2733–2738; (e) Moreno, E.; Perez-Silanes, S.; Gouravaram, S.; Macharam, A.;
Ancizu, S.; Torres, E.; Aldana, I.; Monge, A.; Crawford, P. W. 1,4-Di-N-oxide
quinoxaline-2-carboxamide: Cyclic voltammetry and relationship between electrochemical
behavior, structure, and anti-tuberculosis activity. Electrochim. Acta 2011, 56, 3270–3275;
(f) Moreno, E.; Ancizu, S.; Perez-Silanes, S.; Torres, E.; Aldana, I.; Monge, A. Synthesis
and antimycobacterial activity of new quinoxaline-2-carboxamide 1,4-di-N-oxide deriva-
tives. Eur. J. Med. Chem. 2010, 45, 4418–4426 (g) Jaso, A.; Zarranz, B.; Aldana, I.;
Monge, A. Synthesis of new quinoxaline-2-carboxylate 1,4-dioxide derivatives as anti–
Mycobacterium tuberculosis agents. J. Med. Chem. 2005, 48, 2019–2025.
3. (a) Johnston, J. D.; Chas Pfizer and Co. Inc. Novel antibacterial agents. Patent U.S.
3371090, February 27, 1968; (b) Haddadin, M. J.; Issidorides, C. H.; Lebanon, B.;
Research Corp. Quinoxaline-di-N-oxides. Patent U.S. 3398141, August 20, 1968; (c)
Haddadin, M. J.; Kattan, A. M. A.; Issidorides, C. H. Oxidative elimination of nitrous
acid from nitrate esters: Preparation of mecadox. J. Org. Chem. 1985, 50, 129–130.
4. Edwards, M. L.; Bambury, R. E.; Ritter, H. W. b-Lactam antibiotics with N-oxide side
chains, 1: Quinoxaline N-oxides. J. Med. Chem. 1976, 19, 330–333.
5. Kim, H. K. Richardson-Merrel Inc. 1,4-Dioxidoquinoxalinyl nitrones. Patent U.S.
3644363, February 22, 1972.
6. (a) Brown, D. J. The chemistry of heterocyclic compounds. Quinoxalines 2004, 61; (b)
Katritzky, A. R.; Boulton, A. J. Advances in heterocyclic Chemistry; Academic Press:
New York, 1978; vol. 22, pp. 390–392.
7. Grovenstein, E.; Postman, W.; Taylor, J. W. Reaction of 2-phenylquinoxaline and of
2,3-diphenylquinoxaline with dimethyl acetylenedicarboxylate. J. Org. Chem. 1960, 25,
68–73.
8. Kluge, A. F.; Maddox, M. L.; Lewis, G. S. Formation of quinoxaline monoxides from
reaction of benzofurazan oxide with enones and C-13 NMR correlations of quinoxaline
N-oxides. J. Org. Chem. 1980, 45, 1909–1914.
9. Maroulis, A. J.; Domzaridou, K. C.; Hadjiantoniou–Maroulis, C. P. Synthesis of 2,3-
diphenylquinoxaline-1-oxides by oxidative cyclization of benzyl-a-arylimino oximes.
Synthesis 1998, 1769–1771.
10. Aggarwal, R.; Sumran, G.; Saini, A.; Singh, S. P. Hypervalent iodine oxidation of benzil-a-
arylimino oximes: An efficient synthesis of 2,3-diphenylquinoxaline-1-oxides. Tetrahedron
Lett. 2006, 47, 4969–4971.
11. Zangrando, E.; Trani, M.; Stabon, E.; Carfagna, C.; Milani, B.; Mestroni, G. Synthesis
and molecular structures of nickel(II) and cobalt(II) complexes with 2-(arylimino)-3-
(hydroxyimino)butane. Eur. J. Inorg. Chem. 2003, 14, 2683–2692.